| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.8 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |